SE465109B - Antibakteriell komposition - Google Patents

Antibakteriell komposition

Info

Publication number
SE465109B
SE465109B SE8903625A SE8903625A SE465109B SE 465109 B SE465109 B SE 465109B SE 8903625 A SE8903625 A SE 8903625A SE 8903625 A SE8903625 A SE 8903625A SE 465109 B SE465109 B SE 465109B
Authority
SE
Sweden
Prior art keywords
casein
milk
pneumoniae
influenzae
fraction
Prior art date
Application number
SE8903625A
Other languages
English (en)
Swedish (sv)
Other versions
SE8903625L (sv
SE8903625D0 (sv
Inventor
Bengt Andersson
Catharina Svanborg Eden
Gustav Aniansson
Ragnar Lindstedt
Original Assignee
Bengt Andersson
Catharina Svanborg Eden
Gustav Aniansson
Ragnar Lindstedt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Catharina Svanborg Eden, Gustav Aniansson, Ragnar Lindstedt filed Critical Bengt Andersson
Priority to SE8903625A priority Critical patent/SE465109B/sv
Publication of SE8903625D0 publication Critical patent/SE8903625D0/xx
Priority to KR1019910700615A priority patent/KR920700678A/ko
Priority to CA002044244A priority patent/CA2044244A1/en
Priority to AU66470/90A priority patent/AU633647B2/en
Priority to ES90916537T priority patent/ES2121755T3/es
Priority to JP2515465A priority patent/JPH04503077A/ja
Priority to PCT/SE1990/000702 priority patent/WO1991006308A1/en
Priority to AT90916537T priority patent/ATE170754T1/de
Priority to HU912203A priority patent/HU212935B/hu
Priority to EP90916537A priority patent/EP0454813B1/en
Priority to DE69032646T priority patent/DE69032646T2/de
Priority to DK90916537T priority patent/DK0454813T3/da
Publication of SE8903625L publication Critical patent/SE8903625L/
Priority to NO91912391A priority patent/NO912391L/no
Priority to SU914895868A priority patent/RU2035913C1/ru
Priority to FI913154A priority patent/FI102516B/fi
Publication of SE465109B publication Critical patent/SE465109B/sv
Priority to US08/880,132 priority patent/US5968901A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Catching Or Destruction (AREA)
  • Housing For Livestock And Birds (AREA)
SE8903625A 1989-10-30 1989-10-30 Antibakteriell komposition SE465109B (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition
DK90916537T DK0454813T3 (da) 1989-10-30 1990-10-30 Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet
HU912203A HU212935B (en) 1989-10-30 1990-10-30 Process for producing pharmaceutical compositions, medicinal human aliments and animal food containing casein
DE69032646T DE69032646T2 (de) 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
AU66470/90A AU633647B2 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
ES90916537T ES2121755T3 (es) 1989-10-30 1990-10-30 Fraccion de caseina para uso terapeutico, profilactico y/o diagnostico en infecciones del tracto respiratorio.
JP2515465A JPH04503077A (ja) 1989-10-30 1990-10-30 抗菌組成物
PCT/SE1990/000702 WO1991006308A1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
AT90916537T ATE170754T1 (de) 1989-10-30 1990-10-30 Eine caseinfraktion zur therapeutischen vorbeugenden und/oder diagnostischen verwendung bei atemweginfektionen
KR1019910700615A KR920700678A (ko) 1989-10-30 1990-10-30 항-박테리아 성분물
EP90916537A EP0454813B1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract
CA002044244A CA2044244A1 (en) 1989-10-30 1990-10-30 Antibacterial composition
NO91912391A NO912391L (no) 1989-10-30 1991-06-19 Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.
SU914895868A RU2035913C1 (ru) 1989-10-30 1991-06-28 Средство, ингибирующее связывание s.pneumoniae и/или h. influenzae, и композиция, содержащая это средство
FI913154A FI102516B (fi) 1989-10-30 1991-06-28 Menetelmä kaseiinifraktion valmistamiseksi, jolla on kiinnittymistä es tävä vaikutus bakteereihin
US08/880,132 US5968901A (en) 1989-10-30 1997-06-20 Antibacterial composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Publications (3)

Publication Number Publication Date
SE8903625D0 SE8903625D0 (sv) 1989-10-30
SE8903625L SE8903625L (sv) 1991-05-01
SE465109B true SE465109B (sv) 1991-07-29

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition

Country Status (15)

Country Link
EP (1) EP0454813B1 (ko)
JP (1) JPH04503077A (ko)
KR (1) KR920700678A (ko)
AT (1) ATE170754T1 (ko)
AU (1) AU633647B2 (ko)
CA (1) CA2044244A1 (ko)
DE (1) DE69032646T2 (ko)
DK (1) DK0454813T3 (ko)
ES (1) ES2121755T3 (ko)
FI (1) FI102516B (ko)
HU (1) HU212935B (ko)
NO (1) NO912391L (ko)
RU (1) RU2035913C1 (ko)
SE (1) SE465109B (ko)
WO (1) WO1991006308A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
EP0760674A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
WO1995032728A1 (en) * 1994-05-26 1995-12-07 Abbott Laboratories Inhibition of attachment of h. influenzae to human cells
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
EP0862450A2 (en) * 1995-11-06 1998-09-09 Abbott Laboratories A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein
WO1997026320A2 (en) * 1995-11-06 1997-07-24 Abbott Laboratories Product for inhibition of attachment of h. influenzae to human cells
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
WO2004047778A1 (en) 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
KR20100061441A (ko) 2007-07-06 2010-06-07 래크리드 인코포레이티드 기도 내 생물막을 용해시키기 위한 가수분해 및 산화효소의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
SE8903625L (sv) 1991-05-01
SE8903625D0 (sv) 1989-10-30
KR920700678A (ko) 1992-08-10
DE69032646D1 (de) 1998-10-15
FI102516B1 (fi) 1998-12-31
AU6647090A (en) 1991-05-31
RU2035913C1 (ru) 1995-05-27
HU212935B (en) 1996-12-30
ATE170754T1 (de) 1998-09-15
NO912391D0 (no) 1991-06-19
FI102516B (fi) 1998-12-31
DK0454813T3 (da) 1999-02-01
EP0454813A1 (en) 1991-11-06
JPH04503077A (ja) 1992-06-04
CA2044244A1 (en) 1991-05-01
NO912391L (no) 1991-06-19
EP0454813B1 (en) 1998-09-09
ES2121755T3 (es) 1998-12-16
DE69032646T2 (de) 1999-05-27
FI913154A0 (fi) 1991-06-28
WO1991006308A1 (en) 1991-05-16
AU633647B2 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
JP2631470B2 (ja) 感染防御剤
MXPA02005491A (es) Mezcla de oligosacaridos.
JP2004517067A (ja) 初乳基材組成物
CA2148261A1 (en) Anti-diarrheic product and method of treating rotavirus-associated infection
SE465109B (sv) Antibakteriell komposition
JPH02207089A (ja) 細菌毒素中和剤
JP3694319B2 (ja) 多量体アルファ−ラクトアルブミンを含有する抗菌組成物
JPH08268899A (ja) 病原体感染防御剤
US5968901A (en) Antibacterial composition
JP3163171B2 (ja) ＩｇＡ産生促進剤
JP3072353B2 (ja) 胃炎，胃または十二指腸潰瘍予防食品
KR20180004015A (ko) 도축 혈액 유래 면역단백질의 제조 방법 및 구강 건강 개선을 위해 사용하는 용도
WO1999049876A2 (en) Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof
WO2008040059A1 (en) Anti-bacterially active agents and related methods
JP3794722B2 (ja) ウイルス感染防御作用を有するウシ乳清由来の高分子糖蛋白質混合物、その用途及びその製造法
JP2023096453A (ja) ＩｇＡ産生促進用組成物
EP0989860A1 (en) Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
JPH05238947A (ja) 細菌毒素中和剤
JP2000290194A (ja) 病原性細菌およびウイルス感染防御剤
JP2604332B2 (ja) ビフィズス菌増殖促進飼料
US20070081985A1 (en) Lysozyme fortified milk and milk products
JPH11286452A (ja) 病原性細菌及びウイルス感染防御剤
MXPA94006245A (en) Antibacterial composition
JP2000136148A (ja) 細胞への付着阻害組成物
JP2631470C (ko)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8903625-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8903625-5

Format of ref document f/p: F